Press Release

CSRXP: GSK’S FLOVENT SCHEME DESIGNED TO SIDESTEP ACCOUNTABILITY FOR EGREGIOUS PRICE HIKES

Jan 5, 2024

Big Pharma Giant Switches Popular Brand Name Inhaler to Authorized Generic to Read More

CSRXP: BIG PHARMA RINGS IN 2024 WITH EGREGIOUS PRICE HIKES ON HUNDREDS OF BRAND NAME PRESCRIPTION DRUGS

Jan 2, 2024

Big Pharma Maintains Business-as-Usual Approach to Price-Gouging Americans to Read More

CSRXP: BIG PHARMA DOUBLES DOWN ON EGREGIOUS PRICE HIKES OUTPACING INFLATION

Dec 14, 2023

Administration Announces Drug Makers Increased Prices Faster Than Rate of Read More

CSRXP: BIG PHARMA MAKES EGREGIOUS VACCINE PRICES HIKES OFFICIAL

Sep 14, 2023

Pfizer and Moderna Raise Prices on Vaccines After Years of Taxpayer Read More

CSRxP: Weight Loss Drugs the Latest Target for Big Pharma’s Price-Gouging of American Patients

Aug 24, 2023

Analysis Finds Brand Name Drug Makers Setting U.S. Prices for Obesity Read More

CSRXP: BIG PHARMA INCREASES PRICES ON MORE THAN 100 BRAND NAME DRUGS IN LATEST PRICE HIKING BINGE

Jul 18, 2023

Brand Name Drug Companies Barrel Ahead with Business-As-Usual Approach to Read More

CSRXP: PROPOSAL TO LOOSEN PATENT RULES WOULD FURTHER EMPOWER BIG PHARMA TO BLOCK COMPETITION

Jun 23, 2023

Lawmakers Should Focus on Bipartisan Solutions to Hold Big Pharma Accountable, Read More

CSRXP: SENATORS HAVE OPPORTUNITY TO PASS BIPARTISAN, MARKET-BASED SOLUTIONS TO HOLD BIG PHARMA ACCOUNTABLE

May 11, 2023

U.S. Senate HELP Committee Should Advance Legislation to Boost Competition and Read More

CSRXP: MODERNA BRAZENLY IGNORES OUTRAGE BY MOVING AHEAD WITH EGREGIOUS VACCINE PRICE HIKE

May 4, 2023

Nearly 500 Percent Price Increase on Vaccine Developed with Taxpayer Read More